Inventor · disambiguated record
Michael F. Concino
Also filed as: CONCINO MICHAEL · CONCINO MICHAEL F
27 granted patents·8 pending applications·696 citations·filing 1989–2021
97Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES17UNIV JOHNS HOPKINS5TRANSKARYOTIC THERAPIES INC4SYNAGEVA BIOPHARMA CORP2AVANT IMMUNOTHERAPEUTICS INC1
Top patents by PatentIndex Score
35 records- 0194US5817789AChimeric proteins for use in transport of a selected substance into cellsTRANSKARYOTIC THERAPIES INC·Filed 1995·Granted Oct 6, 1998·99 cites·10 claims
- 0292US5212071ANucleic acids encoding a human C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1989·Granted May 18, 1993·100 cites·64 claims
- 0391US10556015B2Lysosomal targeting of enzymes, and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Feb 11, 2020·7 cites·5 claims
- 0491US9206235B2Peptide linkers for polypeptide compositions and methods for using sameSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Dec 8, 2015·8 cites·22 claims
- 0590US5472939AMethod of treating complement mediated disordersUNIV JOHNS HOPKINS·Filed 1993·Granted Dec 5, 1995·70 cites·37 claims
- 0689US9814764B2Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Nov 14, 2017·9 cites·20 claims
- 0789US8580922B2Peptide linkers for polypeptide compositions and methods for using sameMARTINI PAOLO·Filed 2012·Granted Nov 12, 2013·11 cites·12 claims
- 0889US5981481AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Nov 9, 1999·80 cites·42 claims
- 0988US6027921AChimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteinsTRANSKARYOTIC THERAPIES INC·Filed 1998·Granted Feb 22, 2000·69 cites·49 claims
- 1086US10722559B2Mannose-6-phosphate bearing peptides fused to lysosomal enzymesSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Jul 28, 2020·5 cites·11 claims
- 1186US5856297AHuman C3b/C4b receptor (CR1)UNIV JOHNS HOPKINS·Filed 1995·Granted Jan 5, 1999·58 cites·14 claims
- 1286US5256642ACompositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereofUNIV JOHNS HOPKINS·Filed 1990·Granted Oct 26, 1993·49 cites·13 claims
- 1385US9932568B2Peptide linkers for polypeptide compositions and methods for using sameSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Apr 3, 2018·2 cites·26 claims
- 1485US6262026B1Chimeric proteins for use in transport of a selected substance into cellsTRANSKARYOTIC THERAPIES INC·Filed 1999·Granted Jul 17, 2001·52 cites·38 claims
- 1583US11065307B2Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moietySHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted Jul 20, 2021·2 cites·8 claims
- 1683US6858578B2Chimeric proteins for use in transport of a selected substance into cellsTRANSKARYOTIC THERAPIES INC·Filed 2001·Granted Feb 22, 2005·10 cites·42 claims
- 1782US9932377B2Mitochondrial targeting and therapeutic use thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Apr 3, 2018·2 cites·4 claims
- 1881US8945542B2Methods for treating lysosomal acid lipase deficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Granted Feb 3, 2015·8 cites·3 claims
- 1980US10603364B2Lysosomal targeting and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 31, 2020·2 cites·7 claims
- 2080US6316604B1Human C3b/C4b receptor (CR1)AVANT IMMUNOTHERAPEUTICS INC·Filed 1995·Granted Nov 13, 2001·46 cites·14 claims
- 2175US9260495B2Mitochondrial targeting and therapeutic use thereofKEEFE DENNIS·Filed 2012·Granted Feb 16, 2016·4 cites·7 claims
- 2269US8775146B2Crystal structure of human alpha-N-acetylglucosaminidaseMEIYAPPAN MUTHURAMAN·Filed 2011·Granted Jul 8, 2014·2 cites·5 claims
- 2361US9708590B2Crystal structure of human α-N-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Jul 18, 2017·0 cites·20 claims
- 2459US7229793B1Constructs and cells for production of small peptidesSHIRE HUMAN GENETIC THERAPIES·Filed 2000·Granted Jun 12, 2007·1 cites·41 claims
- 2556US2020376095A1Mannose-6-phosphate bearing peptides fused to lysosomal enzymesSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 2655US10729746B2Recombinant placenta growth factor for treating Duchenne muscular dystrophySHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Aug 4, 2020·0 cites·15 claims
- 2752US2022133863A1Treatment of sanfilippo syndrome type bSHIRE HUMAN GENETIC THERAPIES·Filed 2021·Application pending·0 cites
- 2848US2013330317A1Methods for Treating Lysosomal Acid Lipase DeficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 2948US2003224477A1Optimized promoter constructsFiled 2002·Application pending·0 cites
- 3042US9597376B2Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 21, 2017·0 cites·14 claims
- 3139US2017202929A1Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisSHIRE HUMAN GENETIC THERAPIES·Filed 2017·Application pending·0 cites
- 3237US2018009904A1Lysosomal targeting and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Application pending·0 cites
- 3337US2017267986A1Generation of mannose-6-phosphate containing recombinant alpha-n-acetyl glucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Application pending·0 cites
- 3435US2011318327A1Treatment of sanfilippo syndrome type bCONCINO MICHAEL F·Filed 2011·Application pending·0 cites
- 3529US9453847B2Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereofRUIZ JUAN·Filed 2011·Granted Sep 27, 2016·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Michael F. Concino files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →